BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 33915266)

  • 1. Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence.
    Hampel H; Nisticò R; Seyfried NT; Levey AI; Modeste E; Lemercier P; Baldacci F; Toschi N; Garaci F; Perry G; Emanuele E; Valenzuela PL; Lucia A; Urbani A; Sancesario GM; Mapstone M; Corbo M; Vergallo A; Lista S;
    Ageing Res Rev; 2021 Aug; 69():101346. PubMed ID: 33915266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
    Castrillo JI; Lista S; Hampel H; Ritchie CW
    Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision pharmacology for Alzheimer's disease.
    Hampel H; Vergallo A; Aguilar LF; Benda N; Broich K; Cuello AC; Cummings J; Dubois B; Federoff HJ; Fiandaca M; Genthon R; Haberkamp M; Karran E; Mapstone M; Perry G; Schneider LS; Welikovitch LA; Woodcock J; Baldacci F; Lista S;
    Pharmacol Res; 2018 Apr; 130():331-365. PubMed ID: 29458203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease.
    Hampel H; Caraci F; Cuello AC; Caruso G; Nisticò R; Corbo M; Baldacci F; Toschi N; Garaci F; Chiesa PA; Verdooner SR; Akman-Anderson L; Hernández F; Ávila J; Emanuele E; Valenzuela PL; Lucía A; Watling M; Imbimbo BP; Vergallo A; Lista S
    Front Immunol; 2020; 11():456. PubMed ID: 32296418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
    Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F
    Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease.
    Clark C; Dayon L; Masoodi M; Bowman GL; Popp J
    Alzheimers Res Ther; 2021 Apr; 13(1):71. PubMed ID: 33794997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omics-based biomarkers discovery for Alzheimer's disease.
    Aerqin Q; Wang ZT; Wu KM; He XY; Dong Q; Yu JT
    Cell Mol Life Sci; 2022 Nov; 79(12):585. PubMed ID: 36348101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene networks and systems biology in Alzheimer's disease: Insights from multi-omics approaches.
    Rahimzadeh N; Srinivasan SS; Zhang J; Swarup V
    Alzheimers Dement; 2024 May; 20(5):3587-3605. PubMed ID: 38534018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.
    Hampel H; Toschi N; Babiloni C; Baldacci F; Black KL; Bokde ALW; Bun RS; Cacciola F; Cavedo E; Chiesa PA; Colliot O; Coman CM; Dubois B; Duggento A; Durrleman S; Ferretti MT; George N; Genthon R; Habert MO; Herholz K; Koronyo Y; Koronyo-Hamaoui M; Lamari F; Langevin T; Lehéricy S; Lorenceau J; Neri C; Nisticò R; Nyasse-Messene F; Ritchie C; Rossi S; Santarnecchi E; Sporns O; Verdooner SR; Vergallo A; Villain N; Younesi E; Garaci F; Lista S;
    J Alzheimers Dis; 2018; 64(s1):S47-S105. PubMed ID: 29562524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease in the omics era.
    Sancesario GM; Bernardini S
    Clin Biochem; 2018 Sep; 59():9-16. PubMed ID: 29920246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.
    La Cognata V; Morello G; Cavallaro S
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks.
    Castrillo JI; Oliver SG
    Methods Mol Biol; 2016; 1303():3-48. PubMed ID: 26235058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.
    Badhwar A; McFall GP; Sapkota S; Black SE; Chertkow H; Duchesne S; Masellis M; Li L; Dixon RA; Bellec P
    Brain; 2020 May; 143(5):1315-1331. PubMed ID: 31891371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Omic Technologies in Alzheimer's Disease.
    Avramouli A; Vlamos PM
    Adv Exp Med Biol; 2017; 987():177-184. PubMed ID: 28971457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Big data, integrative omics and network biology.
    Tolani P; Gupta S; Yadav K; Aggarwal S; Yadav AK
    Adv Protein Chem Struct Biol; 2021; 127():127-160. PubMed ID: 34340766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision Medicine.
    Ghosh D; Bernstein JA; Khurana Hershey GK; Rothenberg ME; Mersha TB
    Front Immunol; 2018; 9():2727. PubMed ID: 30631320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: Statistical approach vs machine learning approach.
    Tan MS; Cheah PL; Chin AV; Looi LM; Chang SW
    Comput Biol Med; 2021 Dec; 139():104947. PubMed ID: 34678481
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.